Diisopropylethylamine → {4-[(4-{[Amino(imino)methyl](methyl)amino}butanoyl)amino]butyl}(triphenyl)phosphonium bromide
反応式
[Br-:1].CNCCC[C:7]([NH:9][CH2:10][CH2:11][CH2:12][CH2:13][P+:14]([C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=1)([C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1)=[O:8].Cl.[N:34]1([C:39](=[NH:41])[NH2:40])[CH:38]=[CH:37][CH:36]=N1.[CH:42](N(CC)C(C)C)(C)C>CN(C)C=O>[Br-:1].[NH2:40][C:39]([N:34]([CH3:42])[CH2:38][CH2:37][CH2:36][C:7]([NH:9][CH2:10][CH2:11][CH2:12][CH2:13][P+:14]([C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=1)([C:15]1[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=1)[C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)=[O:8])=[NH:41]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
(4-{[4-(methylamino)butanoyl]amino}butyl)(triphenyl)phosphonium bromide (690 mg, 1.30 mmol) was dissolved in N,N-dimethylformamide (1.4 mL). The resultant solution was treated with 1H-pyrazole-1-carboximidamide hydrochloride (216 mg, 1.47 mmol) and N,N-diisopropylethylamine (0.27 mL, 1.54 mmol). The reaction was stirred overnight at room temperature. More 1H-pyrazole-1-carboximidamide hydrochloride and N,N-diisopropylethylamine can be added to effect further conversion. The reaction mixture in N,N-dimethylformamide was used in the purification without isolation.
後処理
- customThe reaction mixture in N,N-dimethylformamide was used in the purification without isolation
出典と根拠
- ORDレコード
- ord-f5fa93a8df8944bb8766fa34ca559747
- 出典データセット
- uspto-grants-2016_09
- 特許番号
- US09434753B2
反応ノート
読み込み中…